SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Johannes Rudolph, Yao Xiao, Arthur Pardi, Natalie G. Ahn, Slow Inhibition and Conformation Selective Properties of Extracellular Signal-Regulated Kinase 1 and 2 Inhibitors, Biochemistry, 2015, 54, 1, 22

    CrossRef

  2. 2
    Iain Kilty, Lyn H Jones, TAK1 selective inhibition: state of the art and future opportunities, Future Medicinal Chemistry, 2015, 7, 1, 23

    CrossRef

  3. 3
    Raimon Puig de la Bellacasa, Gaël Roué, Patricia Balsas, Patricia Pérez-Galán, Jordi Teixidó, Dolors Colomer, José I. Borrell, 4-Amino-2-arylamino-6-(2,6-dichlorophenyl)-pyrido[2,3-d]pyrimidin-7-(8H)-ones as BCR kinase inhibitors for B lymphoid malignancies, European Journal of Medicinal Chemistry, 2014, 86, 664

    CrossRef

  4. 4
    Hongtao Zhao, Amedeo Caflisch, Discovery of dual ZAP70 and Syk kinases inhibitors by docking into a rare C-helix-out conformation of Syk, Bioorganic & Medicinal Chemistry Letters, 2014, 24, 6, 1523

    CrossRef

  5. 5
    Atli Thorarensen, Neelu Kaila, New spleen tyrosine kinase inhibitors: patent applications published during 2011–2013, Pharmaceutical Patent Analyst, 2014, 3, 5, 523

    CrossRef

  6. 6
    Hala Bakr El-Nassan, Recent progress in the identification of BRAF inhibitors as anti-cancer agents, European Journal of Medicinal Chemistry, 2014, 72, 170

    CrossRef

  7. 7
    Qingwen Zhang, Yuanyuan Diao, Fei Wang, Ying Fu, Fei Tang, Qidong You, Houyuan Zhou, Design and discovery of 4-anilinoquinazoline ureas as multikinase inhibitors targeting BRAF, VEGFR-2 and EGFR, MedChemComm, 2013, 4, 6, 979

    CrossRef

  8. 8
    Iain Kilty, Martin P. Green, Andrew S. Bell, David G. Brown, Peter G. Dodd, Christopher Hewson, Samantha J. Hughes, Christopher Phillips, Thomas Ryckmans, Robert T. Smith, Willem P. Hoorn, Philip Cohen, Lyn H. Jones, TAK1 Inhibition in the DFG-Out Conformation, Chemical Biology & Drug Design, 2013, 82, 5
  9. 9
    Lorenzo Palmieri, Giulio Rastelli, αC helix displacement as a general approach for allosteric modulation of protein kinases, Drug Discovery Today, 2013, 18, 7-8, 407

    CrossRef